231 lines
12 KiB
JSON
231 lines
12 KiB
JSON
{
|
|
"date": "2026-03-03",
|
|
"llm_provider": "google",
|
|
"recommendations": [
|
|
{
|
|
"ticker": "WRB",
|
|
"rank": 1,
|
|
"company_name": "W. R. Berkley Corporation",
|
|
"description": "Insurance holding company operating in commercial lines and reinsurance worldwide.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 88,
|
|
"confidence": 9,
|
|
"risk_level": "low",
|
|
"reason": "This candidate shows exceptional confluence between smart money accumulation and technical strength. 10% Owner Mitsui Sumitomo has aggressively purchased over $130M in stock, including a recent $21.5M buy, signaling massive conviction. This is supported by unusual bullish options flow with a Put/Call ratio of 0.186. Technically, the stock is in an uptrend trading above its 50 and 200 SMAs with a bullish MACD crossover.",
|
|
"entry_price": 73.23999786376953,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "ADM",
|
|
"rank": 2,
|
|
"company_name": "Archer-Daniels-Midland Company",
|
|
"description": "Global food processing and commodities trading corporation.",
|
|
"strategy_match": "options_flow",
|
|
"pipeline": "options_flow",
|
|
"final_score": 85,
|
|
"confidence": 9,
|
|
"risk_level": "moderate",
|
|
"reason": "ADM exhibits one of the strongest options signals in the dataset with a Put/Call ratio of 0.054, indicating overwhelming bullish sentiment in derivatives. This flow aligns with a recent Director purchase of $486k and a strong technical uptrend where the price is 8.4% above the 50 SMA. The bullish MACD divergence further confirms upward momentum. The primary risk is the stock trading near its upper Bollinger Band.",
|
|
"entry_price": 69.61000061035156,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "ENPH",
|
|
"rank": 3,
|
|
"company_name": "Enphase Energy, Inc.",
|
|
"description": "Energy technology company designing and manufacturing solar microinverters and battery energy storage.",
|
|
"strategy_match": "analyst_upgrade",
|
|
"pipeline": "analyst_upgrade",
|
|
"final_score": 82,
|
|
"confidence": 8,
|
|
"risk_level": "high",
|
|
"reason": "Enphase presents a potent short squeeze setup with 22.8% short interest and a recent analyst upgrade acting as a catalyst. The options market is positioning for a move with a bullish P/C ratio of 0.311, and the stock is showing intraday strength of +7.9%. While the trend is strong (above 50/200 SMAs), the high volatility (ATR $3.32) requires tight risk management.",
|
|
"entry_price": 44.709999084472656,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "MRX",
|
|
"rank": 4,
|
|
"company_name": "Marex Group plc",
|
|
"description": "Financial services platform provider offering market access and infrastructure services.",
|
|
"strategy_match": "earnings_play",
|
|
"pipeline": "earnings_play",
|
|
"final_score": 79,
|
|
"confidence": 8,
|
|
"risk_level": "moderate",
|
|
"reason": "With earnings imminent, MRX displays strong pre-event accumulation patterns, including a bullish options Put/Call ratio of 0.129. The stock is in a strong uptrend, trading 9.3% above its 50 SMA with a bullish MACD crossover. The combination of technical momentum and positioning data suggests the market anticipates a positive beat.",
|
|
"entry_price": 43.810001373291016,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "AMGN",
|
|
"rank": 5,
|
|
"company_name": "Amgen Inc.",
|
|
"description": "Biotechnology company discovering and delivering human therapeutics.",
|
|
"strategy_match": "options_flow",
|
|
"pipeline": "options_flow",
|
|
"final_score": 77,
|
|
"confidence": 8,
|
|
"risk_level": "low",
|
|
"reason": "Amgen shows extremely bullish options flow with a volume Put/Call ratio of just 0.022, suggesting heavy call buying interest. The technicals confirm this sentiment, with the stock in a strong uptrend above all key SMAs. While the RSI is approaching overbought levels, the institutional flow provides conviction for continuation. A small insider sale of $375k is negligible compared to the bullish flow.",
|
|
"entry_price": 385.70001220703125,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "SKWD",
|
|
"rank": 6,
|
|
"company_name": "Skyward Specialty Insurance Group, Inc.",
|
|
"description": "Insurance holding company underwriting commercial property and casualty insurance products.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 76,
|
|
"confidence": 8,
|
|
"risk_level": "moderate",
|
|
"reason": "The CEO/Chairman executed a significant cluster purchase of over $1M, a strong vote of confidence. Fundamentals back this trade with 200% earnings growth and a solid uptrend (price above 50 SMA). The stock is trading near its upper Bollinger Band, indicating strong momentum but potential for a short-term pause before continuation.",
|
|
"entry_price": 48.58000183105469,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "ZURA",
|
|
"rank": 7,
|
|
"company_name": "Zura Bio Limited",
|
|
"description": "Clinical-stage biotechnology company developing medicines for immune and inflammatory disorders.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 74,
|
|
"confidence": 7,
|
|
"risk_level": "speculative",
|
|
"reason": "A 10% owner recently purchased a massive $12.5M stake, which is significant relative to the company's $641M market cap. The stock is in a strong uptrend, trading 19% above its 50 SMA, and shows rising On-Balance Volume. The primary risk is the lack of options data to confirm the move, making this a pure equity accumulation play.",
|
|
"entry_price": 6.760000228881836,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "GENB",
|
|
"rank": 8,
|
|
"company_name": "Generate Biomedicines, Inc.",
|
|
"description": "Biomedicine company focusing on generative biology to create new therapeutics.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 72,
|
|
"confidence": 7,
|
|
"risk_level": "speculative",
|
|
"reason": "This is a high-risk, high-reward reversal play driven by a massive $75M insider purchase by a Director. Technical indicators are at extremes with an RSI of 0.0, signaling the stock is deeply oversold and due for a mean reversion bounce. The divergence between the price collapse and the size of the insider buy creates a compelling contrarian opportunity.",
|
|
"entry_price": 12.170000076293945,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "CADL",
|
|
"rank": 9,
|
|
"company_name": "Candel Therapeutics, Inc.",
|
|
"description": "Clinical stage biopharmaceutical company developing immunotherapies for cancer.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 69,
|
|
"confidence": 7,
|
|
"risk_level": "high",
|
|
"reason": "A Director purchased nearly $3M in stock, providing a strong floor of support. This is supported by bullish options flow with a P/C ratio of 0.532. The stock has high short interest (21.4%), making it a prime candidate for a squeeze if buying pressure sustains. However, the stock remains in a technical downtrend, adding risk.",
|
|
"entry_price": 5.110000133514404,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "PATH",
|
|
"rank": 10,
|
|
"company_name": "UiPath, Inc.",
|
|
"description": "Enterprise automation software company specializing in robotic process automation.",
|
|
"strategy_match": "social_dd",
|
|
"pipeline": "social_dd",
|
|
"final_score": 67,
|
|
"confidence": 6,
|
|
"risk_level": "speculative",
|
|
"reason": "UiPath is a potential short squeeze candidate with 23% short interest and social momentum. Options flow is supportive with a bullish Put/Call ratio of 0.273, and the MACD has recently crossed bullishly. The trade is speculative given the broader downtrend, but the confluence of high SI and bullish flow is favorable for a short-term pop.",
|
|
"entry_price": 10.699999809265137,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "CF",
|
|
"rank": 11,
|
|
"company_name": "CF Industries Holdings, Inc.",
|
|
"description": "Manufacturer and distributor of nitrogen fertilizer and other nitrogen products.",
|
|
"strategy_match": "options_flow",
|
|
"pipeline": "options_flow",
|
|
"final_score": 65,
|
|
"confidence": 6,
|
|
"risk_level": "moderate",
|
|
"reason": "The stock demonstrates powerful momentum, trading well above its 50 and 200 SMAs with a Golden Cross. Options flow is exceptionally bullish with a P/C ratio of 0.05. However, this is tempered by significant insider selling ($11M) and an overbought RSI (71), suggesting the move may be extended in the very short term.",
|
|
"entry_price": 104.30000305175781,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "ACHR",
|
|
"rank": 12,
|
|
"company_name": "Archer Aviation Inc.",
|
|
"description": "Developer of electric vertical takeoff and landing (eVTOL) aircraft.",
|
|
"strategy_match": "earnings_play",
|
|
"pipeline": "earnings_play",
|
|
"final_score": 65,
|
|
"confidence": 6,
|
|
"risk_level": "speculative",
|
|
"reason": "Archer shows strong intraday relative strength (+9.7%) and bullish options flow (P/C 0.302) heading into earnings. A bullish MACD crossover supports short-term momentum. The trade is speculative due to the lack of profitability and high volatility, but the market positioning suggests an expectation of positive news.",
|
|
"entry_price": 7.519999980926514,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "GDX",
|
|
"rank": 13,
|
|
"company_name": "VanEck Gold Miners ETF",
|
|
"description": "ETF investing in gold and silver mining companies.",
|
|
"strategy_match": "social_hype",
|
|
"pipeline": "social_hype",
|
|
"final_score": 62,
|
|
"confidence": 6,
|
|
"risk_level": "moderate",
|
|
"reason": "The Gold Miners ETF is in a robust uptrend, trading 16.9% above its 50 SMA. Technicals are strong with a bullish MACD and rising OBV, indicating accumulation. While the RSI is elevated (65.7), it is not yet overbought, leaving room for further upside in the current momentum cycle.",
|
|
"entry_price": 115.33999633789062,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "IDYA",
|
|
"rank": 14,
|
|
"company_name": "IDEAYA Biosciences, Inc.",
|
|
"description": "Precision medicine oncology company focused on targeted therapeutics.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 60,
|
|
"confidence": 6,
|
|
"risk_level": "speculative",
|
|
"reason": "A Director purchased $1.6M in shares, aligning with strong analyst sentiment (Strong Buy consensus). The stock has seen a recent bullish MACD crossover and rising On-Balance Volume. However, bearish options flow acts as a drag on the score, suggesting mixed sentiment among traders.",
|
|
"entry_price": 33.040000915527344,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "TMC",
|
|
"rank": 15,
|
|
"company_name": "TMC the metals company Inc.",
|
|
"description": "Deep-sea minerals exploration company focusing on battery metals.",
|
|
"strategy_match": "social_dd",
|
|
"pipeline": "social_dd",
|
|
"final_score": 58,
|
|
"confidence": 5,
|
|
"risk_level": "speculative",
|
|
"reason": "This is a speculative momentum play driven by social interest and confirmed by a bullish MACD crossover. The stock is seeing rising volume and intraday strength (+5.1%). While options flow is somewhat bullish (P/C 0.271), the fundamentals are weak, making this purely a technical/sentiment trade.",
|
|
"entry_price": 6.380000114440918,
|
|
"discovery_date": "2026-03-03",
|
|
"status": "open"
|
|
}
|
|
]
|
|
} |